EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement

Claire Lis, Lila Pourzand

The UCLA Radiological Science Proceedings · 2025

DOI: 10.5070/rs4.35505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The UCLA Radiological Science Proceedings, 2025. Verfasst von Claire Lis und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amiodarone is an effective class III antiarrhythmic medication, the use of which is limited by its potentially severe side effects and toxicities. When amiodarone pulmonary toxicity (APT) is suspected in patients, amiodarone use should be discontinued. We report a case of APT, with a description of the clinical presentation and radiologic manifestations of the disease and a literature review of purported pathophysiology and treatment.

Zitieren

APA

Lis, C., & Pourzand, L. (2025). Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement. The UCLA Radiological Science Proceedings. https://doi.org/10.5070/rs4.35505

Vancouver

Lis C, Pourzand L. Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement. The UCLA Radiological Science Proceedings. 2025. doi:10.5070/rs4.35505

BibTeX
@article{Lis2025,
  author = {Lis, Claire and Pourzand, Lila},
  title = {Amiodarone Pulmonary Toxicity: A Case of Clinical and Radiologic Improvement},
  journal = {The UCLA Radiological Science Proceedings},
  year = {2025},
  doi = {10.5070/rs4.35505}
}
Kostenlos starten →